Director/PDMR Shareholding

By

Regulatory News | 20 May, 2024

Updated : 14:15

RNS Number : 1431P
Haleon PLC
20 May 2024
 

 

HALEON PLC 

("Haleon" or "the Company")  

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them 

 

20 May 2024: Notification and Public Disclosure in accordance with the requirements of The UK Market Abuse Regulation of Transactions by Persons Discharging Managerial Responsibilities ("PDMRs") and Persons Closely Associated with them.

 

On 17 May 2024, Haleon plc (the "Company") received notification of the following transaction as detailed below.

 

 

 

Details of the person discharging managerial responsibilities / person closely associated  

 

a)  

 

Name  

 

Tobias Hestler

 

 

Reason for the notification  

 

a)  

 

Position/status  

 

 

Chief Financial Officer - PDMR

b)  

 

Initial notification /Amendment  

 

Initial Notification 

 

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor  

 

a)  

 

Name  

 

Haleon plc 

b)  

 

LEI  

 

549300PSB3WWEODCUP19 

 

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted  

 

a)  

 

Description of the financial instrument, type of instrument  

Ordinary Shares of £0.01 each



Identification code  

GB00BMX86B70   



b)  

 

Nature of the transaction  

 

Acquisition of Ordinary Shares as a result of dividend reinvestment

 

 

c)  

 

Price(s) and volume(s)  







Price(s) 

Volume(s) 




£3.31350

13







d)  

 

Aggregated information  

 N/A



- Aggregated volume 




- Price 




e)  

 

Date of the transaction  

 

16 May 2024

f)  

 

Place of the transaction  

 

London Stock Exchange (XLON) 

 

 

Amanda Mellor, Company Secretary

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHBDGDULUDDGSG

Last news